|
29.4.2011 |
LV |
Eiropas Savienības Oficiālais Vēstnesis |
C 128/1 |
Eiropas Savienības lēmumu kopsavilkums par zāļu tirdzniecības atļaujām no 2011. gada 1. janvāra līdz 2011. gada 28. februārim
(publicēts saskaņā ar 13. vai 38. pantu Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004 (1) )
2011/C 128/01
— Tirdzniecības atļaujas izsniegšana (13. pants Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004): Pieņemtas
|
Lēmuma datums |
Zāļu nosaukums |
INN (starptautiskais nepatentētais nosaukums) |
Tirdzniecības atļaujas turētājs |
Ieraksta numurs Kopienas reģistrā |
Farmaceitiskā forma |
AĶT kods (Anatomiski ķīmiski terapeitiskais kods) |
Paziņojuma datums |
||
|
6.1.2011 |
Potactasol |
Topotecanum |
|
EU/1/10/660/001-002 |
Pulveris infūziju šķīduma koncentrāta pagatavošanai |
L01XX17 |
10.1.2011 |
||
|
21.1.2011 |
Docetaxel Teva Pharma |
docetaksels |
|
EU/1/10/662/001-002 |
Koncentrāts un šķīdinātājs infūziju šķīduma pagatavošanai |
L01CD02 |
26.1.2011 |
||
|
21.1.2011 |
Iasibon |
Ibadronskābe |
|
EU/1/10/659/001-010 |
Apvalkotās tabletes Koncentrāts infūziju šķīduma pagatavošanai |
M05BA06 |
25.1.2011 |
||
|
27.1.2011 |
Fluenz |
Gripas vakcīna (dzīva novājināta, intranazālai lietošanai |
|
EU/1/10/661/001-002 |
Deguna aerosola suspensija |
J07BB03 |
1.2.2011 |
||
|
18.2.2011 |
Entacapone Teva |
entakapons |
|
EU/1/10/665/001-004 |
Apvalkotās tabletes |
N04BX02 |
22.2.2011 |
||
|
28.2.2011 |
Daliresp |
roflumilast |
|
EU/1/11/668/001-003 |
Apvalkotās tabletes |
R03DX07 |
2.3.2011 |
||
|
28.2.2011 |
Esbriet |
Pirfenidons |
|
EU/1/11/667/001-003 |
Cietās kapsulas |
L04AX05 |
2.3.2011 |
||
|
28.2.2011 |
Lamivudine / Zidovudine Teva |
Lamivudīna/zidovudīna |
|
EU/1/10/663/001-002 |
Apvalkotās tabletes |
J05AR01 |
2.3.2011 |
||
|
28.2.2011 |
Libertek |
roflumilast |
|
EU/1/11/666/001-003 |
Apvalkotās tabletes |
R03DX07 |
2.3.2011 |
||
|
28.2.2011 |
Xiapex |
Clostridium histolyticum kolagenāze |
|
EU/1/11/671/001 |
Pulveris un šķīdinātājs injekciju šķīduma pagatavošanai |
M09AB02 |
2.3.2011 |
— Tirdzniecības atļaujas grozīšana (13. pants Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004): Pieņemtas
|
Lēmuma datums |
Zāļu nosaukums |
Tirdzniecības atļaujas turētājs |
Ieraksta numurs Kopienas reģistrā |
Paziņojuma datums |
||
|
6.1.2011 |
Invirase |
|
EU/1/96/026/001-002 |
10.1.2011 |
||
|
6.1.2011 |
Irbesartan HCT Winthrop |
|
EU/1/06/377/001-028 |
11.1.2011 |
||
|
6.1.2011 |
Irbesartan Winthrop |
|
EU/1/06/376/001-033 |
11.1.2011 |
||
|
6.1.2011 |
Lucentis |
|
EU/1/06/374/001 |
11.1.2011 |
||
|
6.1.2011 |
Rapamune |
|
EU/1/01/171/001 EU/1/01/171/007-010 EU/1/01/171/013-014 |
11.1.2011 |
||
|
6.1.2011 |
Resolor |
|
EU/1/09/581/001-008 |
11.1.2011 |
||
|
6.1.2011 |
Tepadina |
|
EU/1/10/622/001-002 |
11.1.2011 |
||
|
6.1.2011 |
Yttriga |
|
EU/1/05/322/001 |
10.1.2011 |
||
|
11.1.2011 |
IntronA |
|
EU/1/99/127/011-039 EU/1/99/127/041-044 |
18.1.2011 |
||
|
11.1.2011 |
Pantoloc Control |
|
EU/1/09/519/001-004 |
13.1.2011 |
||
|
11.1.2011 |
Rapiscan |
|
EU/1/10/643/001 |
13.1.2010 |
||
|
13.1.2011 |
Clopidogrel Winthrop |
|
EU/1/08/465/001-020 |
17.1.2011 |
||
|
13.1.2011 |
Copalia |
|
EU/1/06/372/037-039 |
17.1.2010 |
||
|
13.1.2011 |
INOmax |
|
EU/1/01/194/001-002 |
18.1.2011 |
||
|
13.1.2011 |
Iscover |
|
EU/1/98/070/001a-001b EU/1/98/070/002a-002b EU/1/98/070/003a-003b EU/1/98/070/004a-004b EU/1/98/070/005a-005b EU/1/98/070/006a-006b EU/1/98/070/007a-007b EU/1/98/070/008-010 EU/1/98/070/011a-011b EU/1/98/070/012 |
17.1.2011 |
||
|
13.1.2011 |
Nimvastid |
|
EU/1/09/525/001-050 |
17.1.2011 |
||
|
13.1.2011 |
Plavix |
|
EU/1/98/069/001a-001b EU/1/98/069/002a-002b EU/1/98/069/003a-003b EU/1/98/069/004a-004b EU/1/98/069/005a-005b EU/1/98/069/006a-006b EU/1/98/069/007a-007b EU/1/98/069/008-010 EU/1/98/069/011a-011b EU/1/98/069/012 |
17.1.2011 |
||
|
17.1.2011 |
Cancidas |
|
EU/1/01/196/001 EU/1/01/196/003 |
19.1.2011 |
||
|
17.1.2011 |
Kuvan |
|
EU/1/08/481/001-003 |
19.1.2011 |
||
|
17.1.2011 |
Nevanac |
|
EU/1/07/433/001 |
19.1.2011 |
||
|
21.1.2011 |
Abilify |
|
EU/1/04/276/001-020 EU/1/04/276/024-036 |
25.1.2011 |
||
|
21.1.2011 |
Adenuric |
|
EU/1/08/447/001-004 |
25.1.2011 |
||
|
21.1.2011 |
Arzerra |
|
EU/1/10/625/001-002 |
26.1.2011 |
||
|
21.1.2011 |
Cubicin |
|
EU/1/05/328/001-004 |
25.1.2011 |
||
|
21.1.2011 |
Enbrel |
|
EU/1/99/126/001-021 |
25.1.2011 |
||
|
21.1.2011 |
Humira |
|
EU/1/03/256/001-010 |
25.1.2011 |
||
|
21.1.2011 |
INOmax |
|
EU/1/01/194/001-002 |
25.1.2011 |
||
|
21.1.2011 |
Karvea |
|
EU/1/97/049/001-039 |
26.1.2011 |
||
|
21.1.2011 |
Kuvan |
|
EU/1/08/481/001-003 |
25.1.2011 |
||
|
21.1.2011 |
Mixtard |
|
EU/1/02/231/001-023 EU/1/02/231/036-037 |
25.1.2011 |
||
|
21.1.2011 |
Multaq |
|
EU/1/09/591/001-004 |
25.1.2011 |
||
|
21.1.2011 |
Olazax Disperzi |
|
EU/1/09/592/001-005 |
25.1.2011 |
||
|
21.1.2011 |
Pandemrix |
|
EU/1/08/452/001 |
26.1.2011 |
||
|
21.1.2011 |
Pradaxa |
|
EU/1/08/442/001-008 |
25.1.2011 |
||
|
21.1.2011 |
Rapamune |
|
EU/1/01/171/001 EU/1/01/171/007-010 EU/1/01/171/013-014 |
26.1.2011 |
||
|
21.1.2011 |
Rasilez |
|
EU/1/07/405/001-040 |
25.1.2011 |
||
|
21.1.2011 |
Revatio |
|
EU/1/05/318/002 |
25.1.2011 |
||
|
21.1.2011 |
Revlimid |
|
EU/1/07/391/001-004 |
26.1.2011 |
||
|
21.1.2011 |
RotaTeq |
|
EU/1/06/348/001-002 |
26.1.2011 |
||
|
21.1.2011 |
Sprimeo |
|
EU/1/07/407/001-020 |
26.1.2011 |
||
|
21.1.2011 |
Temomedac |
|
EU/1/09/605/001-012 |
26.1.2011 |
||
|
21.1.2011 |
Thymanax |
|
EU/1/08/498/001-008 |
25.1.2011 |
||
|
21.1.2011 |
Valdoxan |
|
EU/1/08/499/001-008 |
26.1.2011 |
||
|
21.1.2011 |
Yentreve |
|
EU/1/04/280/001-008 |
25.1.2011 |
||
|
24.1.2011 |
Apidra |
|
EU/1/04/285/001-036 |
27.1.2011 |
||
|
24.1.2011 |
Ceplene |
|
EU/1/08/477/001 |
27.1.2011 |
||
|
24.1.2011 |
Dafiro |
|
EU/1/06/371/001-039 |
27.1.2011 |
||
|
24.1.2011 |
Eucreas |
|
EU/1/07/425/001-018 |
27.1.2011 |
||
|
24.1.2011 |
Galvus |
|
EU/1/07/414/001-010 EU/1/07/414/018 |
27.1.2011 |
||
|
24.1.2011 |
Isentress |
|
EU/1/07/436/001-002 |
27.1.2011 |
||
|
24.1.2011 |
Jalra |
|
EU/1/08/485/001-011 |
27.1.2011 |
||
|
24.1.2011 |
Lantus |
|
EU/1/00/134/001-037 |
27.1.2011 |
||
|
24.01.2011 |
NutropinAq |
|
EU/1/00/164/003-005 |
27.1.2011 |
||
|
24.1.2011 |
Olanzapine Glenmark |
|
EU/1/09/587/001-017 |
27.1.2011 |
||
|
24.1.2011 |
Olanzapine Glenmark Europe |
|
EU/1/09/588/001-012 |
27.1.2011 |
||
|
24.1.2011 |
Optisulin |
|
EU/1/00/133/001-032 |
27.1.2011 |
||
|
24.1.2011 |
Pelzont |
|
EU/1/08/460/009-011 EU/1/08/460/013-014 |
26.1.2011 |
||
|
24.1.2011 |
Rotarix |
|
EU/1/05/330/001-011 |
27.1.2011 |
||
|
24.1.2011 |
SonoVue |
|
EU/1/01/177/002 |
27.1.2011 |
||
|
24.1.2011 |
Synflorix |
|
EU/1/09/508/001-010 |
27.1.2011 |
||
|
24.1.2011 |
Torisel |
|
EU/1/07/424/001 |
27.1.2011 |
||
|
24.1.2011 |
Tredaptive |
|
EU/1/08/459/009-011 EU/1/08/459/013-014 |
26.1.2011 |
||
|
24.1.2011 |
Trevaclyn |
|
EU/1/08/458/009-011 EU/1/08/458/013-014 |
26.1.2011 |
||
|
24.1.2011 |
Vistide |
|
EU/1/97/037/001 |
27.1.2011 |
||
|
24.1.2011 |
Xarelto |
|
EU/1/08/472/001-010 |
27.1.2011 |
||
|
24.1.2011 |
Xiliarx |
|
EU/1/08/486/001-011 |
27.1.2011 |
||
|
26.1.2011 |
Naglazyme |
|
EU/1/05/324/001-002 |
27.1.2011 |
||
|
27.1.2011 |
Adrovance |
|
EU/1/06/364/001-009 |
1.2.2011 |
||
|
27.1.2011 |
Alimta |
|
EU/1/04/290/001-002 |
1.2.2011 |
||
|
27.1.2011 |
Cymbalta |
|
EU/1/04/296/001-009 |
31.1.2011 |
||
|
27.1.2011 |
Herceptin |
|
EU/1/00/145/001 |
1.2.2011 |
||
|
27.1.2011 |
Icandra |
|
EU/1/08/484/001-018 |
1.2.2011 |
||
|
27.1.2011 |
Menveo |
|
EU/1/10/614/001 |
31.1.2011 |
||
|
27.1.2011 |
Nonafact |
|
EU/1/01/186/001-002 |
1.2.2011 |
||
|
27.1.2011 |
Orgalutran |
|
EU/1/00/130/001-002 |
31.1.2011 |
||
|
27.1.2011 |
Ranexa |
|
EU/1/08/462/001-012 |
1.2.2011 |
||
|
27.1.2011 |
Rasilez HCT |
|
EU/1/08/491/001-080 |
1.2.2011 |
||
|
27.1.2011 |
Regranex |
|
EU/1/99/101/001 |
31.1.2011 |
||
|
27.1.2011 |
Remicade |
|
EU/1/99/116/001-005 |
1.2.2011 |
||
|
27.1.2011 |
Ribavirin Mylan |
|
EU/1/10/634/001-004 |
23.2.2011 |
||
|
27.1.2011 |
RotaTeq |
|
EU/1/06/348/001-002 |
1.2.2011 |
||
|
27.1.2011 |
Sebivo |
|
EU/1/07/388/001-003 |
1.2.2011 |
||
|
27.1.2011 |
Simponi |
|
EU/1/09/546/001-004 |
31.1.2011 |
||
|
27.1.2011 |
Xeristar |
|
EU/1/04/297/001-008 |
1.2.2011 |
||
|
27.1.2011 |
Zomarist |
|
EU/1/08/483/001-018 |
1.2.2011 |
||
|
1.2.2011 |
Ariclaim |
|
EU/1/04/283/008-012 |
3.2.2011 |
||
|
1.2.2011 |
Emend |
|
EU/1/03/262/001-008 |
3.2.2011 |
||
|
1.2.2011 |
Exforge |
|
EU/1/06/370/001-039 |
3.2.2011 |
||
|
1.2.2011 |
Fosavance |
|
EU/1/05/310/001-009 |
3.2.2011 |
||
|
1.2.2011 |
Imprida |
|
EU/1/06/373/001-039 |
3.2.2011 |
||
|
1.2.2011 |
INCRELEX |
|
EU/1/07/402/001 |
3.2.2011 |
||
|
1.2.2011 |
Insulin Human Winthrop |
|
EU/1/06/368/001-168 |
3.2.2011 |
||
|
1.2.2011 |
Insuman |
|
EU/1/97/030/028-195 |
3.2.2011 |
||
|
1.2.2011 |
Irbesartan Teva |
|
EU/1/09/576/001-039 |
3.2.2011 |
||
|
1.2.2011 |
Nivestim |
|
EU/1/10/631/001-009 |
3.2.2011 |
||
|
1.2.2011 |
Orfadin |
|
EU/1/04/303/001-003 |
3.2.2011 |
||
|
1.2.2011 |
Riprazo |
|
EU/1/07/409/001-020 |
3.2.2011 |
||
|
1.2.2011 |
Votrient |
|
EU/1/10/628/001-004 |
3.2.2011 |
||
|
2.2.2011 |
Nplate |
|
EU/1/08/497/001-008 |
4.2.2011 |
||
|
2.2.2011 |
Prevenar |
|
EU/1/00/167/001-008 |
4.2.2011 |
||
|
2.2.2011 |
Prolia |
|
EU/1/10/618/001-004 |
4.2.2011 |
||
|
2.2.2011 |
Replagal |
|
EU/1/01/189/001-006 |
4.2.2011 |
||
|
2.2.2011 |
Vantavo |
|
EU/1/09/572/001-009 |
4.2.2011 |
||
|
8.2.2011 |
Biopoin |
|
EU/1/09/565/001-028 |
10.2.2011 |
||
|
8.2.2011 |
Temodal |
|
EU/1/98/096/001-025 |
14.2.2011 |
||
|
9.2.2011 |
Cimzia |
|
EU/1/09/544/001-002 |
11.2.2011 |
||
|
9.2.2011 |
Karvezide |
|
EU/1/98/085/001-034 |
11.2.2011 |
||
|
9.2.2011 |
Olazax |
|
EU/1/09/597/001-005 |
11.2.2011 |
||
|
9.2.2011 |
Peyona |
|
EU/1/09/528/001-002 |
11.2.2011 |
||
|
9.2.2011 |
Tesavel |
|
EU/1/07/435/001-018 |
11.2.2011 |
||
|
9.2.2011 |
Xelevia |
|
EU/1/07/382/001-018 |
11.2.2011 |
||
|
11.2.2011 |
Aprovel |
|
EU/1/97/046/001-039 |
15.2.2011 |
||
|
11.2.2011 |
Azarga |
|
EU/1/08/482/001-002 |
15.2.2011 |
||
|
11.2.2011 |
Brinavess |
|
EU/1/10/645/001-002 |
15.2.2011 |
||
|
11.2.2011 |
Clopidogrel Krka |
|
EU/1/09/556/001-011 |
15.2.2011 |
||
|
11.2.2011 |
CoAprovel |
|
EU/1/98/086/001-034 |
15.2.2011 |
||
|
11.2.2011 |
Crixivan |
|
EU/1/96/024/001-005 EU/1/96/024/008 EU/1/96/024/010 |
15.2.2011 |
||
|
11.2.2011 |
Eporatio |
|
EU/1/09/573/001-028 |
15.2.2011 |
||
|
11.2.2011 |
Januvia |
|
EU/1/07/383/001-018 |
15.2.2011 |
||
|
11.2.2011 |
Rilonacept Regeneron |
|
EU/1/09/582/001 |
15.2.2011 |
||
|
11.2.2011 |
Zutectra |
|
EU/1/09/600/001 |
15.2.2011 |
||
|
11.2.2011 |
Zyllt |
|
EU/1/09/553/001-010 |
15.2.2011 |
||
|
18.2.2011 |
Actrapid |
|
EU/1/02/230/001-007 EU/1/02/230/016-017 |
22.2.2011 |
||
|
18.2.2011 |
Elaprase |
|
EU/1/06/365/001-003 |
22.2.2011 |
||
|
18.2.2011 |
Keppra |
|
EU/1/00/146/001-032 |
22.2.2011 |
||
|
18.2.2011 |
Mimpara |
|
EU/1/04/292/001-012 |
22.2.2011 |
||
|
18.2.2011 |
Optaflu |
|
EU/1/07/394/001-009 |
22.2.2011 |
||
|
18.2.2011 |
Renagel |
|
EU/1/99/123/005-013 |
22.2.2011 |
||
|
21.2.2011 |
Arzerra |
|
EU/1/10/625/001-003 |
25.2.2011 |
||
|
21.2.2011 |
Baraclude |
|
EU/1/06/343/001-007 |
28.2.2011 |
||
|
21.2.2011 |
Cervarix |
|
EU/1/07/419/001-012 |
25.2.2011 |
||
|
21.2.2011 |
Cialis |
|
EU/1/02/237/001-009 |
23.2.2011 |
||
|
21.2.2011 |
Clopidogrel Teva |
|
EU/1/09/540/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Competact |
|
EU/1/06/354/001-011 |
23.2.2011 |
||
|
21.2.2011 |
Conbriza |
|
EU/1/09/511/001-005 |
23.2.2011 |
||
|
21.2.2011 |
Dukoral |
|
EU/1/03/263/001-003 |
1.3.2011 |
||
|
21.2.2011 |
Dynastat |
|
EU/1/02/209/001-008 |
23.2.2011 |
||
|
21.2.2011 |
Efficib |
|
EU/1/08/457/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Enbrel |
|
EU/1/99/126/001-021 |
25.2.2011 |
||
|
21.2.2011 |
Firazyr |
|
EU/1/08/461/001-002 |
24.2.2011 |
||
|
21.2.2011 |
Glivec |
|
EU/1/01/198/001-013 |
28.2.2011 |
||
|
21.2.2011 |
Humira |
|
EU/1/03/256/001-010 |
23.2.2011 |
||
|
21.2.2011 |
Insulatard |
|
EU/1/02/233/005-007 |
25.2.2011 |
||
|
21.2.2011 |
Intanza |
|
EU/1/08/505/001-006 |
23.2.2011 |
||
|
21.2.2011 |
Ivemend |
|
EU/1/07/437/001-004 |
24.2.2011 |
||
|
21.2.2011 |
Janumet |
|
EU/1/08/455/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Kineret |
|
EU/1/02/203/001-004 |
25.2.2011 |
||
|
21.2.2011 |
Levemir |
|
EU/1/04/278/001-003 |
28.2.2011 |
||
|
21.2.2011 |
Myozyme |
|
EU/1/06/333/001-003 |
28.2.2011 |
||
|
21.2.2011 |
Neupro |
|
EU/1/05/331/001-055 |
25.2.2011 |
||
|
21.2.2011 |
Pritor |
|
EU/1/98/089/001-022 |
25.2.2011 |
||
|
21.2.2011 |
PritorPlus |
|
EU/1/02/215/001-021 |
28.2.2011 |
||
|
21.2.2011 |
Protaphane |
|
EU/1/02/234/005-007 |
25.2.2011 |
||
|
21.2.2011 |
Protopic |
|
EU/1/02/201/001-006 |
28.2.2011 |
||
|
21.2.2011 |
Qutenza |
|
EU/1/09/524/001-002 |
25.2.2011 |
||
|
21.2.2011 |
Ranexa |
|
EU/1/08/462/001-012 |
25.2.2011 |
||
|
21.2.2011 |
Rasilez |
|
EU/1/07/405/001-040 |
25.2.2011 |
||
|
21.2.2011 |
Rasilez HCT |
|
EU/1/08/491/001-080 |
25.2.2011 |
||
|
21.2.2011 |
Remicade |
|
EU/1/99/116/001-005 |
25.2.2011 |
||
|
21.2.2011 |
Ribavirin Teva |
|
EU/1/09/509/001-004 |
24.2.2011 |
||
|
21.2.2011 |
Ribavirin Teva Pharma BV |
|
EU/1/09/527/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Riprazo |
|
EU/1/07/409/001-020 |
28.2.2011 |
||
|
21.2.2011 |
Ristaben |
|
EU/1/10/621/001-018 |
24.2.2011 |
||
|
21.2.2011 |
Ristfor |
|
EU/1/10/620/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Simponi |
|
EU/1/09/546/001-004 |
23.2.2011 |
||
|
21.2.2011 |
Sprimeo |
|
EU/1/07/407/001-020 |
28.3.2011 |
||
|
21.2.2011 |
Stocrin |
|
EU/1/99/111/001-005 EU/1/99/111/008-011 |
25.2.2011 |
||
|
21.2.2011 |
Tamiflu |
|
EU/1/02/222/001-004 |
23.2.2011 |
||
|
21.2.2011 |
Tysabri |
|
EU/1/06/346/001 |
23.2.2011 |
||
|
21.2.2011 |
Velmetia |
|
EU/1/08/456/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Ventavis |
|
EU/1/03/255/001-008 |
23.2.2011 |
||
|
21.2.2011 |
Volibris |
|
EU/1/08/451/001-004 |
2.3.2011 |
||
|
21.2.2011 |
Zylagren |
|
EU/1/09/558/001-010 |
28.2.2011 |
||
|
21.2.2011 |
Zyprexa |
|
EU/1/96/022/016-017 |
23.2.2011 |
||
|
28.2.2011 |
Altargo |
|
EU/1/07/390/001-004 |
4.3.2011 |
||
|
28.2.2011 |
Aranesp |
|
EU/1/01/185/001-022 EU/1/01/185/031-111 |
4.3.2011 |
||
|
28.2.2011 |
Arixtra |
|
EU/1/02/206/001-035 |
2.3.2011 |
||
|
28.2.2011 |
Avastin |
|
EU/1/04/300/001-002 |
4.3.2011 |
||
|
28.2.2011 |
Baraclude |
|
EU/1/06/343/001-007 |
3.3.2011 |
||
|
28.2.2011 |
Clopidogrel Qualimed |
|
EU/1/09/557/001-010 |
4.3.2011 |
||
|
28.2.2011 |
Clopidogrel TAD |
|
EU/1/09/555/001-009 |
4.3.2011 |
||
|
28.2.2011 |
Fabrazyme |
|
EU/1/01/188/001-006 |
4.3.2011 |
||
|
28.2.2011 |
Firazyr |
|
EU/1/08/461/001-002 |
4.3.2011 |
||
|
28.2.2011 |
IDflu |
|
EU/1/08/507/001-006 |
3.3.2011 |
||
|
28.2.2011 |
Ilaris |
|
EU/1/09/564/001-002 |
4.3.2011 |
||
|
28.2.2011 |
Invanz |
|
EU/1/02/216/001-002 |
3.3.2011 |
||
|
28.2.2011 |
Kaletra |
|
EU/1/01/172/001-008 |
4.3.2011 |
||
|
28.2.2011 |
Kinzalkomb |
|
EU/1/02/214/001-015 |
2.3.2011 |
||
|
28.2.2011 |
Kinzalmono |
|
EU/1/98/091/001-014 |
2.3.2011 |
||
|
28.2.2011 |
Micardis |
|
EU/1/98/090/001-020 |
2.3.2011 |
||
|
28.2.2011 |
MicardisPlus |
|
EU/1/02/213/001-023 |
3.3.2011 |
||
|
28.2.2011 |
NovoMix |
|
EU/1/00/142/004-005 EU/1/00/142/009-025 |
3.3.2011 |
||
|
28.2.2011 |
Omnitrope |
|
EU/1/06/332/001-009 |
2.3.2011 |
||
|
28.2.2011 |
Onglyza |
|
EU/1/09/545/011-015 |
3.3.2011 |
||
|
28.2.2011 |
Onglyza |
|
EU/1/09/545/001-010 |
3.3.2011 |
||
|
28.2.2011 |
Osigraft |
|
EU/1/01/179/001 |
4.3.2011 |
||
|
28.2.2011 |
Osseor |
|
EU/1/04/287/001-006 |
4.3.2011 |
||
|
28.2.2011 |
PegIntron |
|
EU/1/00/131/001-050 |
3.3.2011 |
||
|
28.2.2011 |
PREZISTA |
|
EU/1/06/380/001-005 |
4.3.2011 |
||
|
28.2.2011 |
ProQuad |
|
EU/1/05/323/001-013 |
2.3.2011 |
||
|
28.2.2011 |
Protelos |
|
EU/1/04/288/001-006 |
4.3.2011 |
||
|
28.2.2011 |
Quadramet |
|
EU/1/97/057/001 |
4.4.2011 |
||
|
28.2.2011 |
RotaTeq |
|
EU/1/06/348/001-002 |
3.3.2011 |
||
|
28.2.2011 |
Siklos |
|
EU/1/07/397/001-004 |
3.3.2011 |
||
|
28.2.2011 |
Tracleer |
|
EU/1/02/220/001-006 |
3.3.2011 |
||
|
28.2.2011 |
Vedrop |
|
EU/1/09/533/001-003 |
3.3.2011 |
||
|
28.2.2011 |
Ytracis |
|
EU/1/03/250/001 |
4.3.2011 |
— Tirdzniecības atļaujas izņemšana no aprites (13. pants Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004)
|
Lēmuma datums |
Zāļu nosaukums |
Tirdzniecības atļaujas turētājs |
Ieraksta numurs Kopienas reģistrā |
Paziņojuma datums |
||
|
6.1.2011 |
Thelin |
|
EU/1/06/353/001-005 |
11.1.2011 |
||
|
1.2.2011 |
Clopidogrel 1A Pharma |
|
EU/1/09/542/001-007 |
3.2.2011 |
— Tirdzniecības atļaujas izsniegšana (38. pants Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004 (2) ): Pieņemtas
|
Lēmuma datums |
Zāļu nosaukums |
INN (starptautiskais nepatentētais nosaukums) |
Tirdzniecības atļaujas turētājs |
Ieraksta numurs Kopienas reģistrā |
Farmaceitiskā forma |
AĶT kods (Anatomiski ķīmiski terapeitiskais kods) |
Paziņojuma datums |
||
|
27.1.2011 |
Hiprabovis IBR Marker Live |
Dzīvu gE<sup>-</sup> tk<sup>-</sup> liellopu herpes 1 tipa vīrusu (BoHV-1) ar dubultu gēnu delēciju, celms CEDDEL |
|
EU/2/10/114/001-002 |
Liofilizāts suspensijas pagatavošanai |
QI02AD01 |
1.2.2011 |
||
|
11.2.2011 |
Comfortis |
spinosada |
|
EU/2/10/115/001-010 |
Košļājamas tabletes |
QP53BX03 |
15.2.2011 |
||
|
18.2.2011 |
Activyl |
indoksakarba |
|
EU/2/10/118/001-014 |
Spot-on šķīdums |
QP53AX27 |
22.2.2011 |
||
|
18.2.2011 |
Cimalgex |
Cimikoksibs |
|
EU/2/10/119/001-012 |
Tabletes |
QM01AH93 |
24.2.2011 |
||
|
18.2.2011 |
Purevax Rabies |
Rabies rekombinētais kanārijputnu baku vīruss (vCP65) |
|
EU/2/10/117/001-002 |
Suspensija injekcijai |
QI06AX |
22.2.2011 |
||
|
21.2.2011 |
Melosus |
Meloksikams |
|
EU/2/10/116/001-004 |
Suspensija iekšķīgai lietošanai |
QM01AC06 |
24.2.2011 |
— Tirdzniecības atļaujas grozīšana (38. pants Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004): Pieņemtas
|
Lēmuma datums |
Zāļu nosaukums |
Tirdzniecības atļaujas turētājs |
Ieraksta numurs Kopienas reģistrā |
Paziņojuma datums |
||
|
6.1.2011 |
Econor |
|
EU/2/98/010/004-006 EU/2/98/010/017-018 EU/2/98/010/021-025 |
11.1.2011 |
||
|
13.1.2011 |
Duvaxyn WNV |
|
EU/2/08/086/001-003 |
18.1.2011 |
||
|
13.1.2011 |
Palladia |
|
EU/2/09/100/001-003 |
17.1.2011 |
||
|
17.1.2011 |
Zolvix |
|
EU/2/09/101/001-010 |
19.1.2011 |
||
|
21.1.2011 |
Dicural |
|
EU/2/97/003/001-018 |
25.1.2011 |
||
|
21.1.2011 |
Zulvac 8 Ovis |
|
EU/2/09/104/001-002 |
26.1.2011 |
||
|
24.1.2011 |
Poulvac FluFend H5N3 RG |
|
EU/2/06/060/001-002 |
27.1.2011 |
||
|
24.1.2011 |
Rheumocam |
|
EU/2/07/078/001-010 |
26.1.2011 |
||
|
27.1.2011 |
Ingelvac CircoFLEX |
|
EU/2/07/079/001-004 |
1.2.2011 |
||
|
27.1.2011 |
Meloxidyl |
|
EU/2/06/070/005-007 |
1.2.2011 |
||
|
11.2.2011 |
SevoFlo |
|
EU/2/02/035/007 |
15.2.2011 |
— Tirdzniecības atļaujas atlikšana (45. pants Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004)
|
Lēmuma datums |
Zāļu nosaukums |
Tirdzniecības atļaujas turētājs |
Ieraksta numurs Kopienas reģistrā |
Paziņojuma datums |
||
|
24.1.2011 |
Acticam |
|
EU/2/08/088/001-003 |
26.1.2011 |
Ikvienam, kurš vēlas apskatīt publisko novērtējuma ziņojumu par attiecīgajām zālēm un ar tām saistītos lēmumus, jāsazinās ar:
|
The European Medicines Agency |
|
7, Westferry Circus, Canary Wharf |
|
UK - LONDON E14 4H |
(1) OV L 136, 30.4.04, 1. lpp.
(2) OV L 136, 30.4.04, 1. lpp.